16 research outputs found
Demographic, malaria and G6PDd prevalence data by gender and ecosystem in western Sumba.
<p>n = sample number.</p><p><sup>1</sup> Population number was obtained from central agency statistic from each district.</p><p><sup>2</sup> Microscopy diagnosed.</p><p><sup>3</sup> One subject experienced mixed infection of <i>P</i>. <i>falciparum</i> and <i>P</i>. <i>vivax</i>.</p><p><sup>4</sup> Hb < 10 g/dl.</p><p><sup>5</sup> G6PD activities ≤4.6 U/gHb.</p><p><sup>6</sup> Samples screened as G6PD deficient but declined, absent or failed to be DNA extracted.</p><p>Demographic, malaria and G6PDd prevalence data by gender and ecosystem in western Sumba.</p
A) Schematic work flow of the study in western Sumba in 2012 and B) map of G6PD deficiency and malaria prevalences in study sites in Sumba.
<p>Small inlet showed the map of Indonesia and where Sumba island is located.</p
Scatter plot showing the relationship between age and G6PD activity in Sumba.
<p>Scatter plot showing the relationship between age and G6PD activity in Sumba.</p
Impact of Hb level on G6PD activities.
<p>Blue line represents those samples having extremely high G6PD activity and some degree of anemia (R<sup>2</sup> = 0.08) and red line represents those having normal Hb level (R<sup>2</sup> = 0.48) and t-value = 28.6 (p<0.001).</p
Enzymatic parameters from purified G6PD from study subjects in western Sumba according to genotype.
<p>* median of the samples analyzed;</p><p>**cannot be calculated because the interval between the data are too small;</p><p>CI is confidence interval</p><p>Enzymatic parameters from purified G6PD from study subjects in western Sumba according to genotype.</p
Scatter plot of G6PD activities of G6PD deficient and normal subjects from Trinity quantitative versus kinetics assays measured in U/g Hb.
<p>The different colours represented different variant (V in either normal, heterozygous and hemizygous mutants. VL Het, VC Het and CT Het represented heterozygous females having Vanua Lava, Viangchan and Chatham variant respectively. VL Hem, VC Hem and CT Hem represented hemizyogous males having Vanua Lava, Viangchan and Chatham variant respectively.</p
Graphs illustrate diagnostic outcomes for the G6PD RDT (left) and FST (right) among males (top) and females (bottom) across quantitative G6PD activity values for each subject.
<p>A qualitative test classification as deficient is shown in red, and green for normal. Vertical lines within each identify specific diagnostic thresholds (10%, 20%, 30%, 60% and 100%) employed to calculate diagnostic performance characteristics.</p
Chart illustrating the rationale for assessing diagnostic performance of qualitative G6PD screening devices in the context of a clinical decision to offer or withhold primaquine therapy in patients with <i>P</i>. <i>vivax</i> malaria.
<p>Each classification (bold font top), clinical outcome (normal font middle), and risk or benefit (italics bottom) of diagnostic performance appears in each box of classification.</p
Flow-chart of the study in Panenggo Ede where those tests performed in field or field laboratory were confirmed by DNA analysis at the Eijkman Institute in Jakarta, Indonesia.
<p>Flow-chart of the study in Panenggo Ede where those tests performed in field or field laboratory were confirmed by DNA analysis at the Eijkman Institute in Jakarta, Indonesia.</p